US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 62.270
  • +1.210+1.98%
Close Mar 14 16:00 ET
  • 62.270
  • 0.0000.00%
Post 20:01 ET
7.67BMarket Cap18.15P/E (TTM)

Halozyme Therapeutics Key Stats

Halozyme Therapeutics Q4 2024 Earnings Date

Currency:USDFeb 18, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
285.74M
298.01M
+12.27M
Beat Est.
+24.21%
+29.55%
+4.29%
EPS
1.01
1.06
+0.05
Beat Est.
+55.38%
+63.08%
+4.95%
Buy

Mar 16, 2025

Halozyme Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 280.372M--
--2025/Q1-- / 229.294M--
Feb 18, 20252024/Q4298.008M / 285.741M--
Oct 31, 20242024/Q3290.084M / 252.167M--
Aug 6, 20242024/Q2231.353M / 204.941M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 280.372M--
--2025/Q1-- / 229.294M--
Feb 18, 20252024/Q4298.008M / 285.741M--
Oct 31, 20242024/Q3290.084M / 252.167M--
Aug 6, 20242024/Q2231.353M / 204.941M--

Unlock Free Earnings Estimates

Halozyme Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 16, 2025

Buy

  • Buy

    62.50%
  • Hold

    37.50%
  • Sell

    0.00%

Price Target

No Data